UHS stock sentiment todayUniversal Health Services Inc
Sentiment verdict
Gossip first, financials second — HOT at 85% confidence.
Last updated · cached analysis, refreshes periodically
UHS
Universal Health Services IncUHS is capitalizing on a post-pandemic recovery in surgical volumes and a dominant position in the high-margin behavioral health sector.
Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.
You'll show up on boards and The Floor under this name. Add an email later to keep your history.
No account needed. You can add an email later to keep your calls.
Already have an account? Sign in
See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.
Sign in to go Pro →Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for UHS. Not financial advice.
Price · last 12 months
Gossip
Market narrative is centered on the 'catch-up' trade in elective procedures and the acute shortage of mental health beds, where UHS is a market leader. Recent chatter focuses on improved labor stabilization as nursing turnover rates decline across the acute care landscape.
- ·Rising demand for behavioral health services
- ·Stabilizing nursing labor costs and reduced reliance on premium agency staff
- ·Strong earnings beats throughout the recent fiscal year
- ·Increasing patient acuity levels driving higher revenue per admission
Financial
UHS exhibits robust free cash flow and a diversified revenue stream split between acute care hospitals and behavioral health centers. Trading at an attractive forward P/E of roughly 11-12x, it offers a valuation discount relative to its historical growth profile.
- ·Forward P/E: ~11.8x
- ·Operating Margin: ~10-11%
- ·Debt-to-Equity: 0.85 (Manageable leverage)
- ·ROIC: Outperforming industry average at ~9.5%
Conviction
Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.
Mixed conviction — no decisive signal from insiders or the holder base.
- ·No open-market insider trades in the last 120 days.
Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.
Unlock with Pro →Source: SEC EDGAR Form 4 + 13F holder register. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.
Risks
- ·Exposure to government reimbursement rate changes (Medicare/Medicaid)
- ·Legal and regulatory scrutiny regarding behavioral health billing practices
- ·Sensitivity to local labor market wage inflation
Peer temperature
How direct competitors stack up against UHS right now.
- HOTHCAHCA Healthcare
HOTTER — larger scale and superior operational efficiency lead to higher margins and more aggressive share buybacks.
See full analysis → - NEUTRALTHCTenet Healthcare
COLDER — while pivoting to high-margin surgery centers, it carries a significantly higher debt-to-EBITDA profile than UHS.
See full analysis → - NEUTRALACHCAcadia Healthcare
COLDER — pure-play behavioral focus offers less diversification than UHS and trades at a higher P/E multiple on lower revenue volume.
See full analysis →
- UHS-1.2%
- HCA-1.1%
- THC+1.3%
- ACHC-12.7%
Analyst price target
Consensus average of 13 analysts · median 190.00
Source: StockAnalysis.com · updated 2026-09-04
AI-generated analysis for informational purposes only. Not financial advice.